| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.4 |
| mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.4 |
| mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |